Clinical efficacy of garenoxacin for treatment of bacterial respiratory infection secondary to chronic respiratory disease

Trial Profile

Clinical efficacy of garenoxacin for treatment of bacterial respiratory infection secondary to chronic respiratory disease

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Garenoxacin (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Acronyms GARIREO Study
  • Most Recent Events

    • 16 Sep 2016 Status changed from recruiting to completed.
    • 17 Feb 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan
    • 04 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top